Sibanye Stillwater Ltd vs 10X Genomics Inc — how do they compare? Sibanye Stillwater Ltd trades at $8.59 (market cap $5.66B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Sibanye Stillwater Ltd and 10X Genomics Inc are close in size by market cap, and Sibanye Stillwater Ltd pays a 3.89% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| SBSW | TXG | |
|---|---|---|
Market Cap | $5.66B | $5.48B |
Sector | Basic Materials | Health |
52-Week High | $21.12 | $45.80 |
52-Week Low | $7.27 | $11.34 |
Enterprise Value | $7.28B | $5.02B |
Dividend Yield | 3.89% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →